Lepra: puesta al día. Definición, patogénesis, clasificación, diagnóstico y tratamiento

Fitness, 2002, Genetics of suceptibility to leprosy, Genes Inmmun, 3, 441, 10.1038/sj.gene.6363926 Britton, 2004, Leprosy, The Lancet, 363, 1209, 10.1016/S0140-6736(04)15952-7 Han, 2009, Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis, J Bacteriol, 191, 6067, 10.1128/JB.00762-09 2010 Contreras-Steyls, 2011, Lepra importada y su dificultad en el medio actual: a propósito de 7 casos, Actas Dermosifiliogr, 102, 106, 10.1016/j.ad.2010.10.008 Gulia A, Fried I, Massone C. New insights in the pathogenesis and genetics of leprosy. F1000 Medicine Reports. 2010;27:2 Shimoji, 1999, A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion, Proc Natl Acad Sci U S A, 96, 9857, 10.1073/pnas.96.17.9857 Alter, 2011, Leprosy as a genetic disease, Mamm Genome, 22, 19, 10.1007/s00335-010-9287-1 Balagon, 2010, Reactions following completion of 1 and 2 year multidrug therapy (MDT), Am J Trop Med Hyg, 83, 637, 10.4269/ajtmh.2010.09-0586 Bakker, 2004, Population survey to determine risk factors for Mycobacterium leprae transmission and infection, Int J Epidemiol, 33, 1329, 10.1093/ije/dyh266 Davey, 1974, The nasal discharge in leprosy: clinical and bacteriological aspects, Lepr Rev, 25, 121 Ghorpade, 2009, Ornamental tattoos and skin lesions. Tattoo inoculation borderline tuberculoid leprosy, Int J Dermatol, 48, 11, 10.1111/j.1365-4632.2009.03767.x Duncan, 1983, A clinical and immunological study of four babies of mothers with lepromatous leprosy, two of whom developed leprosy in infancy, Int J Lepr Other Mycobact Dis, 51, 7 Ridley, 1966, Classification of leprosy according to immunity. A five-group system, Int J Lepr Other Mycobact Dis, 34, 255 Moschella, 2004, An update on the diagnosis and treatment of leprosy, J Am Acad Dermatol, 51, 417, 10.1016/j.jaad.2003.11.072 Vera-Cabrera, 2011, Case of Diffuse Lepromatous Leprosy Associated with Mycobacterium lepromatosis, J Clin Microbiol, 49, 4366, 10.1128/JCM.05634-11 Rodríguez-Pazos, 2010, Leprorreacción tipo 1 y embarazo, Actas Dermosifiliogr, 101, 190, 10.1016/j.ad.2009.09.005 Garg, 2010, Leprosy: a precipitating factor for complex regional pain syndrome, Minerva Anestesiol, 76, 758 Sehgal, 2007, Management of complications following leprosy: an evolving scenario, J Dermatolog Treat, 18, 366, 10.1080/09546630701364750 Maki, 1999, MR imaging of Dejerine-Sottas disease, AJNR Am J Neuroradiol, 20, 378 Faget, 1944, Bone changes in leprosy, a clinical and roentgenological study of 505 cases, Radiology, 42, 1, 10.1148/42.1.1 Chhabriya, 1985, Bone changes in leprosy. A study of 50 cases, Indian J Lepr, 57, 632 Martínez de Lagrán, 2009, Complicaciones óseas en un paciente con lepra lepromatosa, Actas Dermosifiliogr, 100, 615, 10.1016/S0001-7310(09)71912-X Vargas-Ocampo, 2007, Diffuse leprosy of Lucio and Latapí: a histologic study, Lepr Rev, 78, 248, 10.47276/lr.78.3.248 Hatta, 1995, Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia, Trans R Soc Trop Med Hyg, 89, 381, 10.1016/0035-9203(95)90018-7 Aggarwal, 2010, Inverse sampling to study disease burden of leprosy, Indian J Med Res, 132, 438 Ramaprasad, 1997, Transmission and protection in leprosy: indications of the role of mucosal immunity, Lepr Rev, 68, 301 Silva, 2007, Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions, Trop Med Int Health, 12, 1450, 10.1111/j.1365-3156.2007.01951.x Banerjee, 2010, Multiplex PCR technique could be an alternative approach for early detection of leprosy among close contacts--a pilot study from India, BMC Infect Dis, 10, 252, 10.1186/1471-2334-10-252 da Costa Martins, 2010, Nasal mucosa study of leprosy contacts with positive serology for the phenolic glycolipid 1 antigen, Braz J Otorhinolaryngol, 76, 579 Terencio de las Aguas, 2008, Estado Actual de la Terapéutica de la Lepra, DCMQ, 6, 118 Terencio de las Aguas, 2009, Contagiosidad de la lepra, por Juan de Azúa, Actas Dermosifiliogr, 100, 756, 10.1016/S0001-7310(09)72548-7 Vieira, 2010, Methemoglobinemia and dapsone levels in patients with leprosy, Braz J Infect Dis, 14, 319, 10.1590/S1413-86702010000300022 Kai, 1999, Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene, FEMS Microbiol Lett, 177, 231, 10.1111/j.1574-6968.1999.tb13737.x Britton, 1998, The management of leprosy reversal reactions, Lepr Rev, 69, 225 Walker, 2008, Leprosy type 1 (reversal) reactions and their management, Lepr Rev, 79, 372, 10.47276/lr.79.4.372 Jakeman, 1994, Thalidomide in leprosy reaction, Lancet, 343, 432, 10.1016/S0140-6736(94)92686-7 Heriberto, 1998, Talidomida en dermatología. Revisión de sus orígenes, su actual redescubrimiento y sus nuevas aplicaciones, Dermatología Rev Mex, 42, 252 Ramos, 2011, Disability profile in leprosy patients’ diagnoses in a rural reference leprosy centre in Ethiopia during 1999-2009, Trop Doct, 41, 51, 10.1258/td.2010.100266 Mitsuda, 1937, A study of one hundred and fifty autopsies on cases of leprosy, Int J Lepr Other Mycobact Dis, 5, 53 Azulay, 2002, Vacinação anti-hansênica, An Bras Dermatol, 77, 489 Pönnighaus, 1992, Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi, Lancet, 339, 636, 10.1016/0140-6736(92)90794-4 World Health Organization. WHO recommended MDT regimens. 2012 [consultado 04 Feb 2011]. Disponible en: http://www.who.int/lep/mdt/regimens/en/index.html#